Dr. Cristiana Costa-Chase
Overview
An interest in biological sciences and giving back to the community drove me to medical school, but it has been a desire to advance the field of hematologic malignancies, specifically Multiple Myeloma, that brings me to Duke Health. Cancer is a life-altering diagnosis. With a strong, competent team caring for a patient, there can be many success stories. My goal is to empower my patients to understand their diagnosis and how to manage their disease while providing them with many treatment options along the way.
Dr. Costa-Chase is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. Her top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM), Multiple Myeloma, Smoldering Multiple Myeloma, Cerebral Amyloid Angiopathy, and Bone Marrow Aspiration.
Her clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2400 Pratt St, Durham, NC 27705
Additional Areas of Focus
Dr. Costa-Chase has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
UT MD Anderson Cancer Center
Pei Lin is a Hematologist in Cary, North Carolina. Dr. Lin has been practicing medicine for over 44 years and is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. Her top areas of expertise are Mantle Cell Lymphoma (MCL), Trisomy 3 Mosaicism, Plasmacytoma, Acute Myeloid Leukemia (AML), and Bone Marrow Transplant.
Duke Blood Cancer Center
As a physician and scientist, my ultimate goal is to translate research findings from bench to beside to improve patient care. I focus my research and clinical work on treating blood and bone marrow cancers. Most of the patients in my clinic are blood and bone marrow transplant patients and patients with plasma cell diseases such as multiple myeloma, amyloidosis, POEMS syndrome, and Waldenstrom's macroglobulinemia. The research interests in my lab are on the development of new approaches to enhance hematopoietic stem cell engraftment and reconstitution following blood and bone marrow transplant. Dr. Kang is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Schnitzler Syndrome, Bone Marrow Aspiration, and Bone Graft.
University Of North Carolina At Chapel Hill
Eben Lichtman is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Lichtman is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Smoldering Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Lichtman is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Multiple MyelomaDr. Costa-Chase isDistinguished. Learn about Multiple Myeloma.
- Relapsed Refractory Multiple Myeloma (RRMM)Dr. Costa-Chase isDistinguished. Learn about Relapsed Refractory Multiple Myeloma (RRMM).
- Advanced
- Cardiac AmyloidosisDr. Costa-Chase isAdvanced. Learn about Cardiac Amyloidosis.
- Cerebral Amyloid AngiopathyDr. Costa-Chase isAdvanced. Learn about Cerebral Amyloid Angiopathy.
- Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency
- GTP Cyclohydrolase 1 DeficiencyDr. Costa-Chase isAdvanced. Learn about GTP Cyclohydrolase 1 Deficiency.
- Hereditary Cerebral Amyloid AngiopathyDr. Costa-Chase isAdvanced. Learn about Hereditary Cerebral Amyloid Angiopathy.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Experienced
- Acute Myeloblastic Leukemia with MaturationDr. Costa-Chase isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without MaturationDr. Costa-Chase isExperienced. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Costa-Chase isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Bone Marrow AspirationDr. Costa-Chase isExperienced. Learn about Bone Marrow Aspiration.
- Childhood Acute Myeloid LeukemiaDr. Costa-Chase isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Costa-Chase isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).